NEW YORK – BC Platforms and Genomenon said Tuesday that they have agreed to combine their technologies for rare disease diagnostics and research.
NEW YORK – BC Platforms and Genomenon said Tuesday that they have agreed to combine their technologies for rare disease diagnostics and research.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.